Abstract
The rising incidence of the human immunodeficiency virus (HIV) infection in women and the prolonged survival increases the risk of development of breast cancer in this population. Through December 2001, 38 cases of breast cancer, two occurring in men, have been reported in persons infected with HIV. Between 1995 and 2001, five HIV infected premenopausal women presented with breast cancer to the Karmanos Cancer Institute. Three patients presented 3–5 years after the diagnosis of HIV infection. One patient presented with stage IV breast cancer, three with stage III, and one with stage II disease. Chemotherapy-induced myelosuppression was pronounced in all patients. Two patients had progression of HIV on treatment manifested by a rise in HIV-I RNA or development of opportunistic infections. In general, the outcome of breast cancer in our small series of patients was worse than in a non-HIV population. HIV infection may influence the natural history and treatment of breast cancer.
Similar content being viewed by others
References
Biggar RJ, Rabkin CS: The epidemiology of AIDS-related neoplasm. Hematol/Oncol Clinic North Amer 10: 997–1009, 1996
Remick SC: Non-AIDS-defining cancers. Hematol/Oncol Clinic North Amer 10: 1203–1213, 1996
Parker MS, Leveno DM, Campbell TJ, Worrell JA, Carozza SE: AIDS-related bronchogenic carcinoma: fact or fiction? Chest 113: 154–161, 1998
Chung M, Chang HR, Bland KI, Wanebo HJ: Younger wo-men with breast carcinoma have a poorer prognosis than older women. Cancer 77: 97–103, 1996
Winchester DP: Breast cancer in young women. Surg Clin North Am 76: 279–287, 1996
Frisch M, Biggar RJ, Engles EA, Goedert JJ: Association of cancer with AIDS-related immunosuppression in adults. JAMA 285: 1736–1745, 2001
Phelps RM, Smith DK, Gardner LI, Carpenter CCJ, Klein RS, Jamieson D, Vlahov D, Schuman P, Holmberg SD: Cancer incidence in women with or at risk for HIV infection. Int J Cancer 94(5): 753–757, 2001
Frisch M, Biggar RJ, Engels EA, Goedert JJ: Association of cancer with AIDS-related immunosuppression in adults. JAMA 285(13): 1736–1745, 2001
Spielmann M, Kitschke HJ, Tietje K: Cellular immunity in breast cancer patient. Onkologie 5(suppl): 42–45, 1982
Lee YT, Sheikh KM, Quismorio FP, Friou GJ: Circulating anti-tumor and autoantibodies in breast carcinoma: relation-ship to stage and prognosis. Breast Cancer Res Treat 6: 57–65, 1985
Rotstein S, Blomgren H, Petrini B, Wasserman J, Nilsson B, Baral E: Blood lymphocyte counts with subset analysis in op-erable breast cancer: relation to the extent of tumor disease and prognosis. Cancer 56: 1413–1419, 1985.
Head JF, Elliott RL, McCoy JL: Evaluation of lymphocyte immunity in breast cancer patients. Breast Cancer Res Treat 26: 77–88, 1993
Stewart T, Grayson H, Tsai SJ, Henderson R, Opezl G: Incid-ence of de novo breast cancer in women chronically immun-osuppressed after organ transplantation. Lancet 346: 796–798, 1995
Birkeland SA, Storm HH, Lamm LU, Barlow L, Blohme I, Forsberg B, Eklund B, Fjeldborg O, Friedberg M, Frodin L: Cancer risk after renal transplantation in the Nordic countries, 1964–1986. Int J Cancer 60(2): 183–189, 1995
Lake-Lewin D, Arkel YS: Spectrum of malignancies in HIV positive individuals. Proc Am Soc Clin Oncol 7: 5, 1987 (abstract)
Myers AM, McCarty E, Abernathy C, Moore GE: Breast cancer in a man with HIV infection. AIDS 6: 1218–1220, 1992
Widrick P, Boguniewicz A, Nazeer T, Remick SC: Breast can-cer in a man with human immunodeficiency virus infection. Mayo Clinic Proc 72: 761–764, 1997
Hurley J, Franco S, Gomez-Fernandez C, Reis I, Velez P, Doliny P, Harrington Jr W, Wilkinson J, Kanhoush R, Lee Y: Breast cancer and human immunodeficiency virus: a report of 20 cases. Clin Breast Cancer 2: 215–220, 2001
Harris J, Morrow M, Norton L: Malignant tumors of the breast. In: Devita VT, Hellman S, Rosenberg SA (eds) Cancer: Prin-cipal and Practice of Oncology. 5th edn, Lippincott-Raven, Philadelphia, 1997
Ozer H, Armitage JO, Bennett CL, Crawford J, Demetri GD, Pizzo PA, Schiffer CA, Smith TJ, Somlo G, Wade JC, Wade 3rd JL, Winn RJ, Wozniak AJ, Somerfield MR: 2000 update of recommendation for the use of hematopoietic colony-simulating factors: evidence-based, clinical practice guidelines. American Society of Clinical Oncology Growth Factors Expert Panel. J Clin Oncol 18(20): 3558–3585, 2000
Brenner BG, Friedman G, Margolese RG: The relationship of clinical and therapeutic modality to natural killer cell activity in human breast cancer. Cancer 56: 1543–1548, 1985
Zielinski CC, Muller C, Kubista E, Staffen A, Eibl MM: Ef-fects of adjuvant chemotherapy on specific and non-specific immune mechanisms. Acta Med Austriaca 17: 11–14, 1990
Sewell HF, Halbert CF, Robins RA, Galvin A, Chan S, Biamey RW: Chemotherapy-induced differential changes in lympho-cyte subsets and natural-killer-cell function in patients with advanced breast cancer. Int J Cancer 55: 735–738, 1993
Beitsch P, Lotzova E, Hortobayi G, Pollock R: Natural im-munity in breast cancer patients during neoadjuvant chemo-therapy and after surgery. Surg Oncol 3: 211–219, 1994
Spina M, Nasti G, Simonelli C, Bertola G, Rossi C, Tirelli U: Breast cancer in a woman with HIV infection: a case report. Ann Oncol 5: 661–662, 1994
Brenner BG, Vo C, Wainberg MA: Different effects of breast cancer, HIV-1 infection and chemotherapy on inducible nat-ural immunity. Leukemia 8(suppl 1): S183–S185, 1994
Siddiqui T, Kennedy D, Tennant N, Heimenz J, Masood S: Flow cytometric monitoring of lymphocyte subset in HIV pos-itive breast cancer undergoing CMF adjuvant chemotherapy. Proc Am Soc Clin Oncol 8: 84, 1989 (abstract)
Remick SC, Harper GR, Abdollah MA, McSharpy JJ, Ross JS, Ruckdesch JC: Metastatic breast cancer in a young pa-tient seropositive for human immunodeficiency virus. JNCI 83: 447–448, 1991
Gachupine-Garcia A, Selwyn PA, Bunder NS: Population based study of malignancies and HIV infection among in-jecting drug users in New York City Methadone treatment program, 1985–1991. AIDS 6: 843–848, 1992
Hajjar M, Lacoste D, Brossard G, Morlat P, Dupon M, Salmi LR, Dabis F: Non-acquired immune deficiency syndrome-defining malignancies in a hospital-based cohort of human immunodeficiency virus-infected patients: Bordeaux, France, 1985–1991. Groupe d'Epidemiologie Clinique du SIDA en Aquitaine. J Natl Cancer Inst 84(20): 1593–1595, 1992
Savona S, Ohri A, Lakkis W, Salloum E, Garcia N, Hewlett D: AIDS and malignancy: experience of an inner city primary care hospital. Proc Am Soc Clic Oncol 12: 55, 1993 (abstract)
Mayer AP, Greenberg ML: FNB diagnosis of breast carcinoma associated with HIV infection: a case report and review of HIV associated malignancy. Pathology 28: 90–95, 1996
Cuvier C, Espie M, Extra JM, Marty M: Breast cancer and HIV infection: two case reports. Eur J Cancer 33: 507–508, 1997
Monti F, Ravaioli A, Tassinari D, Desiderio T: Infiltrating lob-ular breast carcinoma in a woman with HIV infection. Eur J Cancer 34: 591, 1998
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
El-Rayes, B.F., Berenji, K., Schuman, P. et al. Breast Cancer in Women with Human Immunodeficiency Virus Infection: Implications for Diagnosis and Therapy. Breast Cancer Res Treat 76, 111–116 (2002). https://doi.org/10.1023/A:1020587504186
Issue Date:
DOI: https://doi.org/10.1023/A:1020587504186